Arecor Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Arecor Therapeutics has a total shareholder equity of £9.5M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £15.4M and £5.9M respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
| Interest coverage ratio | n/a |
| Cash | UK£6.75m |
| Equity | UK£9.53m |
| Total liabilities | UK£5.85m |
| Total assets | UK£15.38m |
Financial Position Analysis
Short Term Liabilities: AREC's short term assets (£11.2M) exceed its short term liabilities (£5.2M).
Long Term Liabilities: AREC's short term assets (£11.2M) exceed its long term liabilities (£700.0K).
Debt to Equity History and Analysis
Debt Level: AREC is debt free.
Reducing Debt: AREC has no debt compared to 5 years ago when its debt to equity ratio was 5.3%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AREC has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: AREC has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 34% each year.